RPG Life Sciences logo

RPG Life Sciences financials and balance sheet

NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap

Last close ₹2,619.60down ₹160.60 (5.78%)BSE ₹2,618.15

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,780.20.

52-week range of traded prices to 23 Oct 2026
₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026
Market cap
₹4,333 Cr923rd largest listed
P/E
36.3
P/B
7.2
Dividend yield
0.92%
ROE
21.0%
ROCE
21.3%
Debt to equity
0.03
Volume, NSE
19,53144.4% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.RPG Life Sciences annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹708 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 0.9% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue708
  2. Materials and goods−252
  3. Employee costs−141
  4. Other expenses−167
  5. Operating profit147
  6. Depreciation−21
  7. Other income+26
  8. One-off items+3.9
  9. Finance costs−0.9
  10. Profit before tax154
  11. Tax−39
  12. Net profit115

What the company owns

  • Plant, investments and other assets₹312 Cr
  • Cash and bank₹157 Cr
  • Inventory₹124 Cr
  • Receivables₹117 Cr
  • Current investments₹84 Cr

What pays for it: net worth and liabilities

  • Net worth₹605 Cr
  • Owed to suppliers₹97 Cr
  • Other liabilities₹71 Cr
  • Borrowings₹20 Cr

Profit and loss

Standalone, ₹ crore, years to March.RPG Life Sciences quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 30 AprMar 2020Filed 6 JunMar 2021Filed 4 MayMar 2022Filed 10 MayMar 2023Filed 9 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 29 Apr
Revenue from operations304347330376389440513582653708
–310297316319354410454494560
Materials and goods bought106115110128131142171185214252
Employee costs––909695100117132126141
Other expenses––979393112122137154167
Operating profit before depreciation–3834597086103128160147
Operating margin–10.8%10.2%15.7%18.0%19.6%20.0%22.0%24.4%20.8%
Materials, % of revenue––33.3%34.0%33.7%32.2%33.3%31.7%32.8%35.6%
Employee costs, % of revenue––27.2%25.5%24.3%22.7%22.8%22.7%19.3%20.0%
Other expenses, % of revenue––29.3%24.7%24.0%25.4%23.8%23.6%23.5%23.6%
Depreciation and amortisation12141516161616172121
Operating profit after depreciation–231843537187111138126
Other income111113571326
Finance costs–442110011
Profit before one-off items and tax–201542547392118150150
One-off items––0−50000834
Profit before tax23201536547392118233154
2747142224305039
Net profit2013112940516888183115
Other comprehensive income––00000−1−1−1
Total comprehensive income––112940516887182115
Net margin6.7%3.9%3.3%7.7%10.3%11.7%13.2%15.1%28.0%16.3%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2017: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations128144163188193222235242279
105118131155–––228256
Materials and goods bought394247505576778591
Employee costs23263040––––74
Other expenses43505565––––90
Operating profit before depreciation23263233–––1423
Operating margin17.8%18.2%19.5%17.5%–––5.8%8.4%
Materials, % of revenue30.7%29.3%28.5%26.5%––––32.7%
Employee costs, % of revenue17.8%17.9%18.4%21.5%––––26.5%
Other expenses, % of revenue33.8%34.6%33.5%34.6%––––32.3%
Depreciation and amortisation89910–––1110
Operating profit after depreciation15172323–––313
Other income300012311
Finance costs998677332
Profit before one-off items and tax–81517211112
One-off items––––––64––
Profit before tax9815172165112
32451−412––
Net profit6711131453112
Net margin4.7%4.6%6.6%6.8%0.4%2.0%22.7%0.4%4.2%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 30 AprMar 2020Filed 6 JunMar 2021Filed 4 MayMar 2022Filed 10 MayMar 2023Filed 9 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 29 Apr
161177216256308375531605
Share capital1313131313131313
Reserves147163203243294362517592
3671100020
78838080103131120161
1387997727
Total assets251267303345419513658793
153139185136154214191263
98128119208266299467530
Net debt356−39−69−115−127−266−221
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 4 MayMar 2022Filed 10 MayMar 2023Filed 9 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 29 Apr
586591947857
678411612413194
−4−311−4−28−43
Receivables625−5−14−36−30
Inventories−12−25−12−66−31
Payables3−21961018
Other working capital−1−199−80
Tax paid−8−19−25−29−53−37
Capital spending92433693665
Free cash flow5041582542−9
−8−35−106−79−4251
−10−14−17−20−27−21
Dividends paid01216202640
Shares bought back000000
Shares issued000000
Net change in cash4017−32−5987
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.RPG Life Sciences dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 30 AprMar 2020Filed 6 JunMar 2021Filed 4 MayMar 2022Filed 10 MayMar 2023Filed 9 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 29 Apr
Earnings per share₹12.37₹8.13₹6.54₹17.54₹24.19₹31.13₹40.90₹53.01₹110.80₹69.64
Diluted earnings per share₹12.37₹8.13₹6.54₹17.54₹24.19₹31.13₹40.90₹53.01₹110.80₹69.64
Dividend per share₹2.80₹2.40₹2.40₹4.00₹7.20₹9.60₹12.00₹16.00₹24.00₹24.00
Book value per share––₹97.05₹106.77₹130.88₹154.66₹186.00₹226.67₹320.80₹366.07
Dividend payout22.6%29.5%36.7%22.8%29.8%30.8%29.3%30.2%21.7%34.5%
Shareholder yield––––0.0%1.3%1.4%0.8%0.7%1.3%
Market cap at the year end (₹ crore)7426314102816419271,1582,5283,7733,072

Ratios

Standalone, years to March.RPG Life Sciences PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 30 AprMar 2020Filed 6 JunMar 2021Filed 4 MayMar 2022Filed 10 MayMar 2023Filed 9 MayMar 2024Filed 8 MayMar 2025Filed 12 JunMar 2026Filed 29 Apr
Revenue growth9.0%14.0%−4.9%13.8%3.6%13.1%16.5%13.5%12.3%8.3%
Operating profit growth––−10.6%76.3%18.2%23.5%18.9%24.8%24.6%−7.8%
Net profit growth76.1%−34.3%−19.6%168.4%37.9%28.7%31.4%29.6%109.0%−37.1%
Earnings per share growth76.0%−34.3%−19.6%168.2%37.9%28.7%31.4%29.6%109.0%−37.1%
––6.7%17.2%20.4%21.8%24.0%25.7%40.5%20.3%
–––10.5 pts3.1 pts1.4 pts2.2 pts1.7 pts14.8 pts−20.2 pts
From the net margin–––9.2 pts5.7 pts2.8 pts2.8 pts3.4 pts22.1 pts−17.0 pts
From asset turnover–––1.6 pts−1.3 pts−0.1 pts−0.3 pts−1.9 pts−5.1 pts−3.0 pts
From borrowing–––−0.3 pts−1.2 pts−1.2 pts−0.3 pts0.2 pts−2.3 pts−0.2 pts
Return on capital employed––9.3%23.4%24.6%27.5%28.3%29.6%26.1%20.1%
Cash conversion––––145.7%125.8%134.3%107.6%42.5%49.1%
Interest cover–6.14.624.567.7136.0281.3246.8222.9141.2
Debt to equity––0.220.040.010.000.000.000.000.03
Receivable days––4362542727314860
Inventory days––1361330214203200159179
Payable days––83127132117138140135141
Cash conversion cycle, days––9668−7812491907299
Working capital days––5448−14834264670
Asset turnover––1.311.451.371.361.341.251.120.98
Assets per rupee of net worth––1.571.541.451.371.361.371.291.28
Sales per rupee of plant––4.004.494.965.905.066.004.053.69
Capital spending to depreciation––––0.521.532.114.061.683.04
Plant being built, % of plant in use––12.3%8.7%12.0%34.1%14.8%87.4%2.5%10.4%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
15.9%
Cash from operations against operating profit
38.4%
Measure10 years5 years3 years
Revenue growth, yearly rate9.7%12.7%11.3%
Profit growth, yearly rate25.8%23.6%19.4%
Return on equity, average–26.5%28.8%
Return on capital employed, average–26.3%25.3%
Operating margin, average18.0%21.4%22.4%
Net margin, average11.6%16.9%19.8%
Asset turnover, average–1.211.11
Cash conversion cycle, days, average–9587
Interest cover, average125.7205.6203.7
Debt to equity, average–0.010.01

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations38422957
Cash from investing−210−7051
Cash from financing−99−68−21
Capital spending22717165
Dividends paid1148640
Shares bought back000
Shares issued for cash000
Borrowings raised202020
Borrowings repaid100

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––787653
Altman Z-scorePublished threshold 1.81––5.194.817.399.679.6214.2721.69–
Beneish M-scorePublished threshold −1.78––––−2.50−3.16−2.70−1.99−1.27−1.87
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−3.626.6021.6315.5425.141.05
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––1.341.210.780.59
Receivables growth less revenue growthOur threshold 0 percentage points–––49.05−12.95−55.66−3.0517.7664.3326.21
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−2.53−102.61–−5.95−1.73−23.9215.40
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−0.271.020.29−0.790.82−0.152.53
Assets under construction, years of additionsOur threshold 2 years of additions–––0.410.842.160.366.610.050.39
Effective tax ratePublished threshold 17.16 per cent9.7933.9428.1720.4125.3529.6426.2225.6121.32–
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––3.88−1.300.74−1.34–
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
11 Sep 2026ICRA Limited (opens in a new tab)Fund-based-Term loan[ICRA]A+Review, OtherStable30
11 Sep 2026ICRA Limited (opens in a new tab)Fund-based-Cash credit[ICRA]A+Review, OtherStable46.25
11 Sep 2026ICRA Limited (opens in a new tab)Interchangeable limits-Others[ICRA]A1Review, Other18.20
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.